Author:
Kim Seokuee,Lee Hyeryeon,Ko Jae-Wook,Kim Jung-Ryul
Funder
Korea Health Industry Development Institute
Ministry of Health & Welfare, Republic of Korea
Subject
Pharmacology (medical),Pharmacology
Reference27 articles.
1. Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis;McCormack;Drugs,2011
2. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis;Becker;Am Heart J,2009
3. Evaluation of the functional status aspects of health-related quality of life of patients with osteoarthritis treated with celecoxib;Zhao;Pharmacotherapy,1999
4. Selective COX-2 inhibitors, NSAIDs and cardiovascular events—is celecoxib the safest choice?;Howes;Ther Clin Risk Manag,2007
5. Cardiovascular risk of nonsteroidal anti-inflammatory drugs and classical and selective cyclooxygenase-2 inhibitors: a meta-analysis of observational studies;Martin Arias;J Clin Pharmacol,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献